Chart-Typ:
Zeitraum:
| Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Reports Fiscal Year and Fourth Quarter 2025 Financial Results | Revenues increased 9% in Q4 2025 compared to Q4 2024, and 12% in FY 2025 compared to FY 2024Net loss improved 27% in Q4 2025 compared to Q4 2024, and 29% in FY 2025 compared to FY 2024EBITDA loss improved... ► Artikel lesen |
| Sonoma Pharmaceuticals, Inc.: Sonoma Pharmaceuticals Announces Registration of Acne Products in the United Kingdom and Launch of the Products in Leading U.K. Pharmacy Chain | BOULDER, CO / ACCESS Newswire / April 22, 2025 / Sonoma Pharmaceuticals, Inc. (Nasdaq:SNOA), a global healthcare leader developing and producing patented Microcyn® technology based stabilized hypochlorous... ► Artikel lesen |
| Pre-market Movers: 2seventy bio, Sonoma Pharmaceuticals, Tenon Medical, Arvinas, NET Power Inc. | LONDON (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 09.00 A.M. ET).In the Green 2seventy bio, Inc. (TSVT) is up over 76% at $4.93.
Sonoma... ► Artikel lesen |
| EQS-News: Metavista3D, Inc.: Metavista Kündigt Neues Unternehmen Mit Fokus Auf Den Verteidigungssektor An | EQS-News: Metavista3D, Inc.
/ Schlagwort(e): Miscellaneous
Metavista Kündigt Neues Unternehmen Mit Fokus Auf Den Verteidigungssektor An
10.07.2025 / 07:00 CET/CEST
Für... ► Artikel lesen |
| Metavista3D, Inc.: Metavista Announces New Entity Focused on Defence Sector | Vancouver, British Columbia--(Newsfile Corp. - July 10, 2025) - Metavista3D Inc. (TSXV: DDD) (FSE: E3T) ("Metavista3D" or the "Company") is pleased to announce a strategic expansion of its research... ► Artikel lesen |
| EQS-News: Metavista3D, Inc.: Metavista Gibt Vereinbarung Mit OEM-Lieferanten Bekannt | EQS-News: Metavista3D, Inc.
/ Schlagwort(e): Miscellaneous
Metavista Gibt Vereinbarung Mit OEM-Lieferanten Bekannt
01.07.2025 / 07:00 CET/CEST
Für den Inhalt der Mitteilung... ► Artikel lesen |
| Acadia Pharmaceuticals Inc.: Acadia Pharmaceuticals and Saniona Announce Initial Positive Results from ACP-711 (formerly SAN711) Phase 1 Study | Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) and Saniona (OMX: SANION) today announced the successful completion of the two originally planned cohorts in their Phase 1 multiple-ascending-dose MAD study... ► Artikel lesen |
| Acadia Pharmaceuticals Inc.: Acadia Pharmaceuticals Submits Marketing Authorization Application to the European Medicines Agency for Trofinetide for the Treatment of Rett Syndrome | -- Filing marks company's first Marketing Authorization Application in Europe
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the company has submitted a Marketing Authorization... ► Artikel lesen |
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ZEO ENERGY CORPORATION finden Sie auf Wallstreet Online.